摘要: A survey was conducted to identify perceptions of cancer and its treatment among the general public, patients, care givers in six countries. The purpose research—the PACE Cancer Perceptions Index (2012)—was share public perspective on progress with stakeholders who make decisions about innovation access treatments order allow patient-centric decisions. results revealed that although understanding is increasing, a number misconceptions persist. Although most respondents recognise has been made majority express satisfaction this progress, they nevertheless want more investment faster new treatments. In particular, there clear agreement collaboration needed across countries between various within addition, does not think their country invests sufficient funds research, concern may be jeopardised by current difficult economic times.
sci-hub.se 参考文章(4)
Karen Facey, Antoine Boivin, Javier Gracia, Helle Ploug Hansen, Alessandra Lo Scalzo, Jean Mossman, Ann Single, Patients' perspectives in health technology assessment: A route to robust evidence and fair deliberation International Journal of Technology Assessment in Health Care. ,vol. 26, pp. 334- 340 ,(2010) , 10.1017/S0266462310000395
Joseph A. DiMasi, Henry G. Grabowski, The cost of biopharmaceutical R&D: is biotech different? Managerial and Decision Economics. ,vol. 28, pp. 469- 479 ,(2007) , 10.1002/MDE.1360
Michael Dickson, Jean Paul Gagnon, Key factors in the rising cost of new drug discovery and development Nature Reviews Drug Discovery. ,vol. 3, pp. 417- 429 ,(2004) , 10.1038/NRD1382
Joseph A DiMasi, Ronald W Hansen, Henry G Grabowski, The price of innovation: new estimates of drug development costs Journal of Health Economics. ,vol. 22, pp. 151- 185 ,(2003) , 10.1016/S0167-6296(02)00126-1